BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,070 filers reported holding BAXTER INTL INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $5,267,000 | -70.0% | 67,925 | -66.8% | 0.10% | -68.8% |
Q4 2021 | $17,584,000 | +9.1% | 204,850 | +2.2% | 0.33% | +6.2% |
Q3 2021 | $16,116,000 | -11.3% | 200,375 | -11.2% | 0.31% | -5.2% |
Q2 2021 | $18,159,000 | -6.2% | 225,575 | -1.7% | 0.32% | -10.2% |
Q1 2021 | $19,350,000 | +69.5% | 229,425 | +61.3% | 0.36% | +50.2% |
Q4 2020 | $11,414,000 | +211.7% | 142,247 | +152.7% | 0.24% | +517.9% |
Q1 2018 | $3,662,000 | +0.6% | 56,300 | 0.0% | 0.04% | 0.0% |
Q4 2017 | $3,639,000 | +3.0% | 56,300 | 0.0% | 0.04% | -2.5% |
Q3 2017 | $3,533,000 | -69.9% | 56,300 | -71.0% | 0.04% | -71.6% |
Q2 2017 | $11,739,000 | +52.7% | 193,900 | +30.8% | 0.14% | +51.6% |
Q1 2017 | $7,686,000 | -77.2% | 148,200 | -79.1% | 0.09% | -81.5% |
Q3 2016 | $33,741,000 | +5.2% | 708,850 | -0.1% | 0.50% | +1.2% |
Q2 2016 | $32,072,000 | +16.4% | 709,250 | +5.8% | 0.50% | +7.3% |
Q1 2016 | $27,542,000 | +7.7% | 670,450 | 0.0% | 0.46% | -2.7% |
Q4 2015 | $25,578,000 | +69.0% | 670,450 | +45.5% | 0.48% | +50.2% |
Q3 2015 | $15,137,000 | – | 460,800 | – | 0.32% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |